Skip to search.
 TSX Up 0.03% TSX Ventures Down 0.11%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS
15.10 Up 0.54(3.71%) Jul 2, 4:00PM EDT
Add to Portfolio
Prev Close:14.56
Open:14.62
Bid:14.75 x 1000
Ask:N/A
1y Target Est:18.22
Beta:4.36
Next Earnings Date: 7-Aug-15BCRX Earnings announcement
Day's Range:14.48 - 15.23
52wk Range:7.85 - 16.43
Volume:1,541,788
Avg Vol (3m):898,646
Market Cap:1.10B
P/E (ttm):N/A
EPS (ttm):-0.72
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BCRXUp 3.71%1.10B
GSKUp 0.28%102.06B
RHHBYUp 0.09%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):62.20
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.98
Quarterly EPS Est (Jun-15) :-0.23
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):0.67

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback